Creosol, also called 2-methoxy-4-methylphenol or 4-methylguaiacol, is a smoky phenolic constituent associated with pyrolytic and tar-like aromatic materials rather than with fresh floral oils. In the AromaForge archive it appears in rectified birch tar context, where it helps explain the oil's leathery-smoky character. The public evidence base is modest: identity and flavor-safety coverage are solid, one anti-inflammatory paper points to activity within bamboo-vinegar fractions, and fragrance-safety coverage exists, but direct human-use evidence remains sparse.
Aroma and practical use
- Use the recorded smoky, phenolic, tar-like, spicy, woody descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A PubMed-indexed bamboo-vinegar study reported lower inflammatory mediator expression and NLRP3 inflammasome activation, and the search snippet identified creosol as the major anti-inflammatory compound within that tested mixture.
A PubMed-indexed bamboo-vinegar study reported lower inflammatory mediator expression and NLRP3 inflammasome activation, and the search snippet identified creosol as the major anti-inflammatory compound within that tested mixture.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A field and laboratory entomology abstract reported that the 4-methyl-substituted guaiacol derivative, i.e. creosol, elicited stronger repellent responses from tsetse flies than guaiacol in that study system.
A field and laboratory entomology abstract reported that the 4-methyl-substituted guaiacol derivative, i.e. creosol, elicited stronger repellent responses from tsetse flies than guaiacol in that study system.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedWHO/JECFA lists creosol as having no safety concern at current levels of intake when used as a flavouring agent, which is a food-flavor exposure statement rather than a blanket topical-safety claim.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
A PubMed-indexed RIFM fragrance ingredient safety assessment exists for 2-methoxy-4-methylphenol, supporting that fragrance-safety review literature is available even though the detailed conclusions were not fully extracted here.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
ros linked inflammasome modulation in mixture context
The bamboo-vinegar paper interpreted anti-inflammatory effects through reduced reactive-oxygen-species generation and NLRP3 inflammasome activation, and identified creosol as the major anti-inflammatory compound in that mixture context.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Direct constituent-specific human clinical evidence for creosol was not verified in this pass.
- The main bioactivity source identified creosol within a complex bamboo-vinegar mixture, so constituent-level interpretation should stay conservative.
- No constituent-specific dermal maximum or phototoxic standard for isolated creosol was verified from a directly readable primary source in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.